Pulmonary spindle cell carcinoma with hemothorax: A rare case report
International Journal of Surgery Case Reports, ISSN: 2210-2612, Vol: 94, Page: 107103
2022
- 1Citations
- 12Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Case Description
Pulmonary spindle cell carcinoma is a type of variant sarcomatoid carcinoma, which is a very rare case. A 53-year-old male presented with weakness, 95% oxygen saturation with nasal cannula 3 L/min, asymmetric chest movement, and problem in the right lung (dull to percussion, and low vesicular auscultation). X-ray and CT-Scan supported hemothorax and lung malignancies in the right lung. The patient had a chest drain inserted which confirmed the hemothorax and was transferred to the operating room for emergency thoracotomy to stop the bleeding. Bleeding was still massive so re-thoracotomy and lobectomy were performed. The lung tissue was examined for anatomical pathology, and the results showed spindle cell carcinoma. The patient was given pemetrexed and carboplatin chemotherapy. The patient refused to continue therapy and died 3 months after the first chemotherapy. Immunohistochemistry markers are the parameter for diagnosis of pulmonary spindle cell carcinoma that is highly positive for pan-cytokeratin, vimentin, and Ki67. The treatment is similar to other NSCLC, depending on the staging, and may include surgical resection, chemotherapy, and radiotherapy. Pulmonary spindle cell carcinoma is very rare and has a poor prognosis, especially in the presence of hemothorax.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2210261222003492; http://dx.doi.org/10.1016/j.ijscr.2022.107103; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85129239733&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/35658283; https://linkinghub.elsevier.com/retrieve/pii/S2210261222003492; https://dx.doi.org/10.1016/j.ijscr.2022.107103
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know